Berlin - Delayed Quote EUR

Liquidia Corp (LT4.BE)

11.97

+0.19

+(1.61%)

At close: 9:52:09 PM GMT+2

3 Top Growth Companies With Strong Insider Ownership

In a market marked by significant rebounds and volatility, with the Dow surging over 1,000 points and major indices like the S&P 500 and Nasdaq seeing substantial gains, investors are keenly observing companies that not only promise growth but also have strong insider ownership. Such ownership can often signal confidence from those closest to the company's operations, making these stocks potentially appealing in today's fluctuating economic landscape.

Simply Wall St. yesterday

TAL

LQDA

TBBB
Great week for Liquidia Corporation (NASDAQ:LQDA) institutional investors after losing 1.5% over the previous year

Key Insights Institutions' substantial holdings in Liquidia implies that they have significant influence over the...

Simply Wall St. 9 days ago

LQDA
UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

MORRISVILLE, N.C., April 01, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that the company will provide an overview of the company’s business at a fireside chat at the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9, 2025, beginning at 8:45 a.m. ET. Access to a webcast of the presentation will be available on the “Investors” page of

GlobeNewswire 22 days ago

LQDA
Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

MORRISVILLE, N.C., April 01, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that the company will provide an overview of the company’s business at a fireside chat at the 24th Annual Needham Virtual Healthcare Conference on Tuesday, April 8, 2025, beginning at 8:45 a.m. ET. Access to a webcast of the presentation will be available on the “Investors” page of Li

GlobeNewswire 22 days ago

LQDA
Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder

FDA sets PDUFA goal date of May 24, 2025MORRISVILLE, N.C., March 28, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) resubmission for YUTREPIA™ (treprostinil) inhalation powder to treat pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with in

GlobeNewswire 26 days ago

LQDA
Liquidia Announces Poster Presentations at the American Thoracic Society (ATS) 2025 International Conference

- Data from the ASCENT study of LIQ861 (YUTREPIA™) in PH-ILD patients highlights safety, tolerability, exploratory changes in six-minute walk distance, cardiac effort and quality of life - Case study highlights the long-term safety and tolerability of LIQ861 (YUTREPIA) in a PAH patient transitioning from parenteral treprostinil in INSPIRE study MORRISVILLE, N.C., March 27, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies fo

GlobeNewswire 27 days ago

LQDA
Discover 3 Top Growth Companies With Significant Insider Ownership

As the United States market experiences a rally with major indices like the S&P 500 and Nasdaq posting gains, investor sentiment is buoyed by reports of potential tariff reductions. In this environment, growth companies with significant insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the company's operations and prospects.

Simply Wall St. 30 days ago

BHC

LQDA

ALTI
Liquidia Full Year 2024 Earnings: Misses Expectations

Liquidia ( NASDAQ:LQDA ) Full Year 2024 Results Key Financial Results Revenue: US$14.0m (down 20% from FY 2023). Net...

Simply Wall St. last month

LQDA
Q4 2024 Liquidia Corp Earnings Call

Q4 2024 Liquidia Corp Earnings Call

Thomson Reuters StreetEvents last month

LQDA
Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Lags Revenue Estimates

Liquidia Technologies (LQDA) delivered earnings and revenue surprises of -21.05% and 43.11%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks last month

LQDA
Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update

Targeting final FDA approval of YUTREPIA™ after expiration of regulatory exclusivity on May 23, 2025Advancing pipeline of inhaled treprostinil products in clinical studiesStrengthened financial position by up to $100 million via amendment to existing financing agreement with HealthCare Royalty Partners (HCRx)Company to host webcast today at 8:30 a.m. ET MORRISVILLE, N.C., March 19, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative the

GlobeNewswire last month

LQDA
Liquidia Corporation Strengthens Financial Position by Amending HealthCare Royalty Agreement to Incrementally Add Up to $100 Million

MORRISVILLE, N.C., March 18, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that it has entered into a sixth amendment to its agreement with HealthCare Royalty (“HCRx”) to provide for up to an additional $100 million of financing in three tranches (the “Sixth Amendment”), subject to certain closing conditions including the funding conditions discussed below.

GlobeNewswire last month

LQDA
One Liquidia Insider Raised Their Stake In The Previous Year

From what we can see, insiders were net buyers in Liquidia Corporation's ( NASDAQ:LQDA ) during the past 12 months...

Simply Wall St. last month

LQDA
Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025

MORRISVILLE, N.C., March 12, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that it will report its full year 2024 financial results on Wednesday, March 19, 2025. The company will host a live webcast at 8:30 a.m. Eastern Time to discuss its financial results and provide a corporate update. The live webcast will be available on Liquidia's website at https://li

GlobeNewswire last month

LQDA
Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors

BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking and capital markets, as well as extensive knowledge of the healthcare and life scie

GlobeNewswire last month

LQDA

AVIR
US Growth Stocks With High Insider Ownership Seeing Up To 48% Revenue Growth

As the U.S. stock market experiences fluctuations with major indexes like the Dow Jones and S&P 500 facing potential weekly losses, investors are increasingly focusing on identifying resilient growth opportunities. In this environment, companies with high insider ownership can be particularly appealing due to their alignment of interests between management and shareholders, often resulting in strong revenue growth even amidst broader market volatility.

Simply Wall St. last month

T

T-PA

TPC
Liquidia Technologies (LQDA) Moves 5.7% Higher: Will This Strength Last?

Liquidia Technologies (LQDA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks 2 months ago

LQDA
3 US Growth Stocks With Strong Insider Ownership

As the United States stock market experiences a surge, with major indices like the S&P 500 and Dow Jones Industrial Average posting significant gains, investor interest in growth companies remains high. In this environment, stocks with strong insider ownership can be particularly appealing as they often indicate confidence from those closest to the company's operations and strategy.

Simply Wall St. 3 months ago

LQDA

PX

T
Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference

MORRISVILLE, N.C., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that Dr. Roger Jeffs, Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, beginning at approximately 9:45 a.m. Pacific Time (12:45 p.m. Eastern Time) at the Westin St. Francis in San Francisco, California. Access to a live, audio-only webcast will be available on the “Investors” page of Liquidia’s website at https://liquid

GlobeNewswire 3 months ago

LQDA
Jim Cramer’s Hidden Gem: Why Liquidia Corporation (LQDA) Is the Undervalued Stock You Need to Know

We recently published a list of the Jim Cramer’s Hidden Gems: 10 Undervalued Stocks You Need to Know. In this article, we are going to take a look at where Liquidia Corporation (NASDAQ:LQDA) stands against other undervalued stocks you need to know according to Jim Cramer. With the year coming to a close, Jim Cramer, […]

Insider Monkey 3 months ago

LQDA

^RUT

Performance Overview

Return	LT4.BE	S&P 500 (^GSPC)
YTD	+7.26%	-8.60%
1-Year	-3.16%	+6.02%
3-Year	+129.66%	+25.85%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Liquidia Corp (LT4.BE)

3 Top Growth Companies With Strong Insider Ownership

Great week for Liquidia Corporation (NASDAQ:LQDA) institutional investors after losing 1.5% over the previous year

UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder

Liquidia Announces Poster Presentations at the American Thoracic Society (ATS) 2025 International Conference

Discover 3 Top Growth Companies With Significant Insider Ownership

Liquidia Full Year 2024 Earnings: Misses Expectations

Q4 2024 Liquidia Corp Earnings Call

Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Lags Revenue Estimates

Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update

Liquidia Corporation Strengthens Financial Position by Amending HealthCare Royalty Agreement to Incrementally Add Up to $100 Million

One Liquidia Insider Raised Their Stake In The Previous Year

Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025

Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors

US Growth Stocks With High Insider Ownership Seeing Up To 48% Revenue Growth

Liquidia Technologies (LQDA) Moves 5.7% Higher: Will This Strength Last?

3 US Growth Stocks With Strong Insider Ownership

Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference

Jim Cramer’s Hidden Gem: Why Liquidia Corporation (LQDA) Is the Undervalued Stock You Need to Know

Performance Overview